|
Our Mission: Democratize AI-powered disease diagnostics worldwide. |
Our Approach: Build global partnerships to co-develop solutions for local diseases. |
Our Platform: Octopi, an automated microscope to detect deadly diseases like malaria. |
Octopi in a field site at Kagera, Tanzania, 2025
Global collaborations
Our work is deeply rooted in global partnerships and insights from experts worldwide.
Our Platform Technology
Our technology stems from research at Stanford University and Cephla, and is adopted and co-developed by partners around the world.
Example workflow for detecting malaria parasites in field site, with sample to result possible in <10 minutes
|
Reimagining microscopy: Analyzing millions of cells in minutes, Octopi can accurately detect diseases like malaria orders of magnitude faster than expert microscopists. |
Multi-disease capability on a single platform: Using standard glass slide interface and modular hardware, Octopi is adaptable to diseases like TB, SCD, NTDs, cervical cancer, and more. |
Octopi's technology was featured in the World Changing Ideas List 2025 by Fast Company
Voices from the field
Our partners discuss the need and impact of Octopi for malaria detection
Enabling a global platform for AI-powered disease diagnostics
|
Cephla Inc.
705 N Shoreline Blvd, Mountain View, CA 94043 USA |